Rite Aid Corporation, a prominent American drugstore chain, is contemplating shuttering 400 to 500 outlets amidst bankruptcy deliberations. While talks are ongoing, the company's massive $3.3 billion debt looms large. Concurrently, federal lawsuits and a DOJ action over alleged mishandling of opioid prescriptions challenge the pharmacy's operations.
Currently, Rite Aid is negotiating the terms of a bankruptcy plan, which may result in the permanent closure of its stores, now numbering more than 2,100 in the 17 U.S. states. It was reported that some individuals familiar with the ongoing talks with creditors told the Wall Street Journal that the company suggested closing up to 500 pharmacies in bankruptcy.
It was also said that Rite Aid also proposed to either sell or allow creditors to take over the remaining drug stores. As per Fox Business, there is one group of bondholders that prefers to liquidate a greater number of stores, and officials are said to be discussing the exact number.
But while there is an ongoing talk, Rite Aid said they have not yet made any decision. It was already reported that the drugstore chain is planning to file for bankruptcy protection due to the more than $3.3 billion debt it has incurred. It also faces thousands of federal lawsuits about its alleged part in the sweeping spread of opioids.
Washington Examiner reported that Rite Aid is also being confronted by huge pressure from the U.S. Department of Justice, which filed a lawsuit against the company for allegedly "knowingly" filling up unlawful prescriptions for controlled substances. The DOJ said the pharmacy giant missed "obvious red flags" that the medications it sold were being abused by customers such as medical fentanyl and oxycodone.
Rite Aid disagreed with how the government described its handling of opioid medications. It also denied the claims it is filling illegal prescriptions.
Photo by: Chance Pereira/Flickr(CC BY-SA 2.0)


Xiaomi Shares Drop After Weak Q1 Earnings Amid Rising Smartphone Costs
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
Goldman Sachs to Pay $500M in 1MDB Shareholder Fraud Settlement
S&P 500 Hits Record High as Tech Rally Slows Amid Iran Peace Uncertainty
Morgan Stanley Names Top AI Security and Data Center Stocks for 2026
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
Dow Hits Record High as Healthcare and Consumer Stocks Lead Wall Street Rally
U.S.-Iran Talks May Take Days as Oil Prices React to Strait of Hormuz Tensions
European Stocks Rise as AI Optimism Offsets U.S.-Iran Tensions
Dollar Gains Slightly as U.S.-Iran Tensions Keep Forex Markets on Edge
Yen Stays Near Intervention Zone as Iran Conflict Supports U.S. Dollar
Toshifumi Suzuki, Founder of Seven-Eleven Japan, Dies at 93
Lam Research Expands AI-Powered Semiconductor Tools and Arizona Operations
NHS shakeup: if it sounds like we’ve been here before, it’s because we have
Asian Stocks Slip as U.S.-Iran Tensions Weigh on Markets; South Korea’s KOSPI Hits Record High
Boeing Wins Fraud Lawsuit Over 737 MAX Filed by LOT Polish Airlines 



